Day 1, September 28

Dr Robert Johnson
09:15

Opening Keynote Presentation - BARDA

Dr Robert Johnson, Director, Influenza And Emerging Infectious Diseases Division, HHS/BARDA
Tony Fauci
09:45

Vaccinology for the 21st century in addressing emerging infectious diseases

Panel discussion
12:00

Exhibition Hall & Partnering

Last mile delivery

13:39

SARS-CoV-2: Going Viral

One Health

Supply & Logistics
13:40

Introduction to Supply & Logistics Channel

Emerging and Infectious
13:40

Introduction to Emerging and Infectious Diseases Channel

Clinical Development
13:40

Why is an HIV vaccine needed?

  • Why is it taking so long to develop a vaccine
  • Update on current antiviral and bnAb pipeline
Dr Frank Tomaka, Senior Director, Clinical Lead HIV/STI Vaccines, Janssen Vaccines & Prevention B.V.
Partnerships
13:40

Introduction to Partnerships Channel

Hansilla Alaigh, Director, External Development, Emergent BioSolutions

Funding and Partnering and Accelerating Development

Supply & Logistics
14:05

Data-driven last-mile health delivery systems

Evelyn Castle, Executive Director, Co-founder, eHealth Africa
Supply & Logistics
14:30

Panel: How can industry work with vaccine non-profits to improve last mile delivery?

  • What are the main challenges faced?
  • What should industry consider to better suit our needs?
    • Temperature stable vaccines, other considerations for products on the market
  • Case studies of what works / doesn’t work for current products
15:10

Exhibition Hall & Partnering

Clinical trial logistics and product planning

Tackling AMR

Developing a Vaccine Revolution Against Infectious Diseases

Veterinary
15:50

AMR: What’s the strategy?

  • Insight on how the human health and veterinary medicine industry is contributing to the fight against AMR
Supply & Logistics
16:20

Successful storage and distribution strategies to operationalize global vaccine clinical trials

  • Challenges and opportunities of conducting clinical trials during a pandemic
  • Leveraging innovation to fast-track patient-centric trials
  • Road map to commercialization: supply chain considerations
Clinical Development
16:20

Reserved

Respiratory
16:35

Regulatory guidance and pathway to developing next generation respiratory vaccines

Why the world needs HIV vaccines

Supply & Logistics
16:50

Urgent challenges and solutions in COVID-19 vaccine delivery

Jay McHarg, CEO, AeroSafe Global
17:20

Exhibition Hall & Partnering

last published: 28/Sep/20 15:15 GMT